Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/31/2002US6500927 For screening for agonists and antagonists of the splice variant receptor activities and to methods of measuring splice variant binding activities
12/31/2002US6500926 Isolated polypeptides of given sequence; use for detection of the presence of epstein barr virus
12/31/2002US6500925 Use for detecting human disease states and chromosomal abnormalities associated with thyroid dysfunction such as thyroid disorders, ischemia reperfusion injury, inflammatory disorders; antibodies
12/31/2002US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors
12/31/2002US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis
12/31/2002US6500922 Native polypeptide factors that are capable of association with the intracellular domain of tnf-r2 and participate in the intracellular post-receptor signaling of tnf biological activities
12/31/2002US6500920 Inhibitor of transforming growth factor β and A method of inhibiting the biological effects of transforming growth factor
12/31/2002US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
12/31/2002US6500918 Conjugate comprising an antinociceptive agent covalently bonded to a blood component
12/31/2002US6500801 Treatment for Dutch elm disease
12/31/2002US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
12/31/2002US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor
12/31/2002US6500667 Reducing cellular production of amyloid beta from amyloid precursor protein, transforming or transfecting cells in vitro with an anti-sense reagent capable of reducing asp2 polypeptide by reducing asp2 transcription or translation
12/31/2002US6500664 Growth differentiation factor-8 family nucleic acid sequences
12/31/2002US6500663 Unique associated Kaposi's sarcoma virus sequences and uses thereof
12/31/2002US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones
12/31/2002US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins
12/31/2002US6500648 Methods for recombinant peptide production
12/31/2002US6500646 Drugs in which peptides having affinity specific for phospholipids, preferably those which are contained in the constituents of lipid bilayers forming the surface layers of cells and of which the proportion in the outer part of each
12/31/2002US6500645 N-terminally extended proteins expressed in yeast
12/31/2002US6500643 Human high affinity choline transporter
12/31/2002US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast
12/31/2002US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element,
12/31/2002US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor
12/31/2002US6500638 Nucleotide sequences for use in the diagnosis and treatment of prostate cancer
12/31/2002US6500637 Neurogenesis inducing genes
12/31/2002US6500636 Chimeric pre-activated transcription factors
12/31/2002US6500635 Insulin-like growth factor binding protein (IGFBF-5)
12/31/2002US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor
12/31/2002US6500630 Measuring level of pregnancy- associated plasma protein-a (papp-a) in biological sample from a non-pregnant patient; comparing level with that of control subjects; diagnosing inflammatory condition based on level of papp-acontrol
12/31/2002US6500626 Combining in aqueous binding conditions an agent, a bax polypeptide capable of binding to a bcl-2 polypeptide under the aqueous binding conditions, a bcl-2 polypeptide capable of binding to a bax polypeptide under the aqueous binding
12/31/2002US6500625 Methods for diagnosing cancer or precancer based upon hnRNP protein expression
12/31/2002US6500624 Kainate-binding, human CNS receptors of the EAA3 family
12/31/2002US6500617 Recombining plurality of nucleic acids comprising segments derived from a gene that confers resistance to pests such as insects producing a library; expressing encoded polypeptides and assaying
12/31/2002US6500613 Isolated pneumococcal surface protein c, pspc, of strepto-coccus pneumoniae having alpha-helical, proline rich and repeat regions
12/31/2002US6500611 Inviable virus particles as scaffolds for constructing flexible detection systems
12/31/2002US6500472 For enriching foods or beverages, anemia treatment
12/31/2002US6500437 Fusion protein comprising specified amino acid sequence
12/31/2002US6500436 Administering botulinium toxin component coupled to substance p
12/31/2002US6500435 Vaccine comprising at least three isolated actinobacillus pleuropneumoniae cytolysin proteins having specified amino acid sequences
12/31/2002US6500433 Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II
12/31/2002US6500431 Inhibitors of angiogenesis and tumor growth
12/31/2002US6500429 Polypeptide analog of a cationic polypeptide such as neurotrophic factor-3 (nt-3) having a different amino acid sequence so that the isoelectric point is lower and the in vivo circulating life and/or absorption is increased
12/31/2002US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof
12/31/2002US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3)
12/31/2002US6500420 Agents can be used to regulate blood flow to a wound site promoting wound healing
12/31/2002US6500419 Method for introducing and expressing RNA in animal cells
12/31/2002US6500417 Mutants of interleukin-3, containing one or more deletions and/or one or more substitutions, with interesting pharmacological properties as interleukin-3 antagonist
12/31/2002US6500267 Killing and/or degrading and vaporizing microorganisms and organic deposits with ultraviolet light in a heat exchanger; efficiency
12/31/2002CA2245006C Protein expression system
12/31/2002CA2201944C Analogs of keratinocyte growth factor having enhanced temperature stability
12/31/2002CA2157867C High molecular weight surface proteins of non-typeable haemophilus
12/31/2002CA2096532C New human recombinant gamma-interferon
12/31/2002CA2069460C Methods and compositions for preparation and use of a herpes protease
12/31/2002CA2022285C Enhancement of naphthalene dioxygenase activity during microbial indigo production
12/31/2002CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine
12/27/2002WO2002103513A1 Essential and important genes of pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents
12/27/2002WO2002103362A2 Cancer associated protein
12/27/2002WO2002103359A1 NUCLEAR ENVELOPE PROTEIN RECOGNIZED BY ATYPICAL p-ANCA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND AUTOIMMUNE LIVER DISEASES
12/27/2002WO2002103060A2 Enterovirus nucleic acids and methods for detecting enterovirus
12/27/2002WO2002103057A1 Methods for identifying modulators of nf-kb activity
12/27/2002WO2002103026A2 Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
12/27/2002WO2002103024A2 Stabilized proteins with engineered disulfide bonds
12/27/2002WO2002103019A1 Peptides participating in prionization of heterogenous erf3
12/27/2002WO2002103018A1 Novel polypeptide and use thereof
12/27/2002WO2002103017A1 Nucleic acids isolated in neuroblastoma
12/27/2002WO2002103016A2 Human tachykinin-related splice variants and compositions thereof
12/27/2002WO2002103015A2 Abca10 transporter
12/27/2002WO2002103012A1 Chimaeric phages
12/27/2002WO2002103006A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002WO2002103005A1 Guanosine triphosphate-binding protein-coupled receptors
12/27/2002WO2002103000A2 Methods for modulating gap junctions
12/27/2002WO2002102999A1 Attenuated circovirus
12/27/2002WO2002102996A1 Male contraceptives
12/27/2002WO2002102994A2 Human secreted proteins
12/27/2002WO2002102993A2 Human secreted proteins
12/27/2002WO2002102992A2 Novel nucleic acids, polypeptides, methods of making, and uses thereof
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102986A2 Novel human transporter proteins and polynucleotides encoding the same
12/27/2002WO2002102982A2 Hoxd3 compositions ad methods for improved wound healing
12/27/2002WO2002102977A2 Characterization of a membrane estrogen receptor
12/27/2002WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002WO2002102974A2 Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
12/27/2002WO2002102970A2 Flax (linum usitatissimim l.) seed-specific promoters
12/27/2002WO2002102853A2 Cd4-specific antibody trx1 and uses therefor
12/27/2002WO2002102852A2 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeut ic use
12/27/2002WO2002102851A1 Use of abalone processing waste
12/27/2002WO2002102850A2 Gene therapy for hemophilia a
12/27/2002WO2002102849A2 Bcmp-101, a cancer associated protein
12/27/2002WO2002102848A2 Nucleic acid and amino acid sequences of a vegf variant
12/27/2002WO2002102847A1 Novel ligand and dna thereof
12/27/2002WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002WO2002102845A1 Process for producing silk fibroin-origin functional polypeptide and utilization thereof
12/27/2002WO2002102844A1 Haemocyanin from abalone and process of purification thereof
12/27/2002WO2002102843A2 Gene expression during meningococcus adhesion
12/27/2002WO2002102842A1 Immunogenic helicobacter surface proteins and their use
12/27/2002WO2002102841A2 Identification and cloning of the receptor gene for symbiotic nitrogen fixation
12/27/2002WO2002102840A2 Multiners of class i major histocompatibility complexes cantaining modified beta2-microglobulin proteins
12/27/2002WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof
1 ... 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 ... 2916